Evidence map›Paper›PMID 41893811›Full record

ArticleVaccines2026

Generation and Evaluation of a Multi-Epitope Vaccine Against

Nicolas D Prather, Jadelynn Aki, Sean Jeffreys, Bernard P Arulanandam, Chiung-Yu Hung, Jieh-Juen Yu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nicolas D PratherDepartment of Molecular Microbiology and Immunology, University of Texas at San Antonio, San Antonio, TX 78249, USA.ORCID 0009-0006-8104-2414
Jadelynn AkiDepartment of Molecular Microbiology and Immunology, University of Texas at San Antonio, San Antonio, TX 78249, USA.ORCID 0009-0009-4758-2224
Sean JeffreysDepartment of Molecular Microbiology and Immunology, University of Texas at San Antonio, San Antonio, TX 78249, USA.ORCID 0000-0002-5837-721X
Bernard P ArulanandamDepartment of Immunology, Tufts University School of Medicine, Boston, MA 02111, USA.ORCID 0000-0002-4815-5306
Chiung-Yu HungDepartment of Molecular Microbiology and Immunology, University of Texas at San Antonio, San Antonio, TX 78249, USA.ORCID 0000-0003-1091-3420
Jieh-Juen YuDepartment of Molecular Microbiology and Immunology, University of Texas at San Antonio, San Antonio, TX 78249, USA.ORCID 0000-0001-8901-3366

Funding

National Institute of Allergy and Infectious Diseases 1R21AI180267
6 · The paper itself

Abstract

BACKGROUND/

objectivesMultidrug-resistant (MDR)

methodsWe utilized immunoinformatics to identify candidate peptides containing both putative B- and T-cell epitopes from proteins associated with

resultsSubcutaneous vaccination of C57BL/6 mice with AMEV1 or AMEV2, formulated with TiterMax adjuvant, conferred 60% and 80% protection, respectively, against intraperitoneal

conclusionsThese study results provide insights into the application of reverse vaccinology to combat the rise of MDR

Indexed as

Acinetobacter baumanniimultidrug-resistant bacteriamulti-epitope vaccinenosocomial pathogenreverse vaccinologyvaccine

Identifiers

PMID41893811
PMCPMC13030376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.